US Edition
Early COVID-19 Vaccine Patent In China Raises New Questions For U.S. Investigators
Summary by Zero Hedge
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.7 Articles
7 Articles
All
Left
Center
Right
4
The hypothesis that the Covid-19 virus may have leaked from a laboratory in Wuhan was long considered a conspiracy theory. Biologist Sigrid Bratlie believes the world has been deceived.
·Oslo, Norway
Read Full Article
Early COVID-19 Vaccine Patent In China Raises New Questions For U.S. Investigators - Nemos News Network
A Chinese patent for a COVID-19 vaccine filed just weeks after the virus emerged in the United States is drawing fresh scrutiny from U.S. investigators examining the origins of the pandemic and potential efforts to conceal early information about the virus. The February 24, 2020, patent application – submitted by three Chinese entities affiliated with the People’s Liberation Army – outlines a process for developing a “COVID-19 protein vaccine.” …
Coverage Details
Total News Sources7
Leaning Left0Leaning Right4Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
